The group of companies Boehringer Ingelheim embraces diverse cultures and multifaceted societies.
Our core principle for one of the world's most renowned pharmaceutical companies is summarized in production through innovation and with our long-standing experience of over 125 years in your field, we offer you the care and safety you deserve.
Through conducting clinical trials and research studies, the sponsors of Boehringer Ingelheim ensure the effectiveness of the drugs they process and aim to optimize their potentials through scientific creativity to provide the corresponding treatments for diseases with dangerous unmet medical needs.
It is based on three pillars:
The scope of our applications focuses on the following research areas with great medical need:
With our contribution to these therapeutic areas we continue to help millions of patients suffering from cardiovascular and metabolic diseases. Our recent clinical studies highlight new applications for the treatment of diabetes, obesity, non-alcoholic steatohepatitis (NASH), diabetic retinopathy, and chronic kidney disease. Concurrent applied therapies can contribute to reducing cardiovascular morbidity and mortality.
Our specialized researchers are engaged in fully integrated centers under laboratory controls for the high-quality production of our products. The company's philosophy is based on the standard technique of drug discovery worldwide with the help of research.
